2m 2m 2m 2m 2m 2m 2m
PDS BIOTECH-B (PDSB)
NASDAQ
$1.08$0.00 (0.00%)
Price as of Jun 03, 2026 7:55 PM EDT- $60.3MMarket Cap
- -24.18%1-Year Change
- BiotechnologyIndustry
PDS BIOTECH-B (PDSB)
$1.08$0.00 (0.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -19.0M -15.69% | -22.6M -18.72% | -27.8M -5.67% | -29.4M +161.50% | |
Depreciation and Amortization Expense | 21,836 +3.43% | 21,112 +21.62% | 17,359 +20,084.88% | 86 -98.39% | |
Total Operating Expenses | 31.5M -13.15% | 36.3M -15.62% | 43.0M +3.29% | 41.7M +94.37% | |
Operating Profit | -31.5M -13.15% | -36.3M -15.62% | -43.0M +3.29% | -41.7M +94.37% | |
Interest Income | 1.2M -51.60% | 2.5M -13.37% | 2.9M +210.42% | 935,180 +21,418.18% | |
Interest Expense | -4.1M +90.95% | -2.2M -48.68% | -4.2M +219.47% | -1.3M N/A | |
Interest Income and Expense and Net | -2.9M -914.72% | 356,458 +127.36% | -1.3M +241.69% | -381,339 -8,874.48% | |
Total Nonoperating Income and Expense | -4.1M +90.95% | -2.2M +65.65% | -1.3M +241.69% | -381,339 N/A | |
Income before Taxes | -35.7M -7.31% | -38.5M -13.23% | -44.3M +5.46% | -42.1M +96.19% | |
Income Taxes | -1.2M +34.59% | -869,169 -38.18% | -1.4M +17.28% | -1.2M -73.45% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -34.5M -8.28% | -37.6M -12.42% | -42.9M +5.11% | -40.9M +141.48% | |
Net Income from Continuing Operations Applicable to Common | -35.7M -7.31% | -38.5M -13.23% | -44.3M +5.46% | -42.1M +96.19% | |
Basic EPS and Net Income | -0.74 -28.16% | -1.03 -25.90% | -1.39 -2.80% | -1.43 +116.67% | |
Diluted EPS and Net Income | -0.74 -28.16% | -1.03 -25.90% | -1.39 -2.80% | -1.43 +116.67% | |
Basic Weighted Average Shares | 46.4M +27.25% | 36.5M +17.77% | 31.0M +8.23% | 28.6M +11.73% | |
Diluted Weighted Average Shares | 46.4M +27.25% | 36.5M +17.77% | 31.0M +8.23% | 28.6M +11.73% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 26.7M -35.93% | 41.7M -26.29% | 56.6M -23.38% | 73.8M +13.15% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 26.7M -35.93% | 41.7M -26.29% | 56.6M -23.38% | 73.8M +13.15% | |
Total Current Assets | 28.3M -37.29% | 45.1M -23.71% | 59.1M -22.78% | 76.5M +14.42% | |
Accumulated Depreciation | 175,727 +14.19% | 153,891 +15.90% | 132,779 +15.04% | 115,420 +0.07% | |
Property and Plant and Equipment and Net | 120,184 -15.38% | 142,020 +5.88% | 134,132 N/A | 0 -100.00% | |
Total Long-Term Assets | 120,184 -15.38% | 142,020 +5.88% | 134,132 N/A | 0 -100.00% | |
Total Assets | 30.5M -32.77% | 45.4M -23.63% | 59.4M -22.88% | 77.0M +14.60% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 5.1M -58.96% | 12.5M +200.00% | 4.2M N/A | N/A N/A | |
Total Current Liabilities | 9.5M -44.50% | 17.1M +25.36% | 13.6M +38.78% | 9.8M +161.47% | |
Total Long-Term Debt | 11.7M +27.47% | 9.2M -52.81% | 19.5M -15.27% | 23.0M N/A | |
Total Long-Term Liabilities | 2.1M +200.00% | 700,000 N/A | 0 N/A | 0 -100.00% | |
Total Liabilities | 21.2M -19.40% | 26.4M -20.76% | 33.3M +0.77% | 33.0M +727.74% | |
Retained Earnings | -216.6M +18.94% | -182.1M +26.03% | -144.5M +42.28% | -101.6M +67.30% | |
Total Stockholders Equity | 9.3M -51.32% | 19.0M -27.27% | 26.1M -40.61% | 44.0M -30.39% | |
Total Shares Outstanding | 54.9M +44.46% | 38.0M +14.78% | 33.1M +9.69% | 30.2M +6.05% | |
Cash Flow | |||||
Cash from Operating Activities | -27.8M -20.78% | -35.0M +4.14% | -33.6M +30.83% | -25.7M +105.91% | |
Capital Expenditures | 0 -100.00% | 29,000 N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | 0 +100.00% | -29,000 N/A | N/A N/A | N/A N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 12.8M -36.72% | 20.2M +23.28% | 16.4M -52.24% | 34.3M -29.87% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Return on Assets | -90.95% +26.66% | -71.81% +14.05% | -62.97% +11.13% | -56.66% +64.25% | |
Return on Equity | -244.16% +46.51% | -166.65% +36.09% | -122.46% +60.68% | -76.21% +103.48% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 2.98 +13.00% | 2.64 -39.14% | 4.33 -44.36% | 7.79 -56.24% | |
Cash Ratio | 2.82 +15.45% | 2.44 -41.21% | 4.15 -44.79% | 7.52 -56.73% | |
Debt-to-Equity Ratio | 1.82 +59.59% | 1.14 +26.07% | 0.91 N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.55 +15.57% | 0.48 +20.05% | 0.40 N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow